Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Mary A. Cifaldi

Mary A. Cifaldi publishes mostly in Rheumatology, Hematology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Autoimmune and Inflammatory Disorders Research.

OpenAlex
World rank
#1,133,370
of 7,710,434 ranked researchers
Rank in United States
#365,603
of 1,627,098
Works
38
Citations
1.6k
Citations per work
42.4
h-index
22
i10-index 29Top 19% in Rheumatology
Mary A. Cifaldi

What does Mary A. Cifaldi research?

Mary A. Cifaldi's work is mostly in Medicine (58%), Immunology and Microbiology (5%), Health Professions (4%).

Health Sciences: 24 works · 62.6% of their workMedicine: 22 works · 58.1% of their workRheumatology: 16 works · 41.1% of their workHematology: 3 works · 7.1% of their workPulmonary and Respiratory Medicine: 2 works · 5.4% of their workEpidemiology: 2 works · 4.5% of their workHealth Professions: 2 works · 4.5% of their workGeneral Health Professions: 2 works · 4.5% of their workEverything else: 12 works · 32.0% of their workLife Sciences: 2 works · 5.4% of their workImmunology and Microbiology: 2 works · 5.4% of their workImmunology: 2 works · 5.4% of their workTHEIR WORKMary A. Cifaldi38works
Life Sciences5%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2258.1%
    2. Health Professions24.5%
  2. Everything else1232.0%
    1. Immunology and Microbiology25.4%
  1. 1Rheumatology41% of their works
  2. 2Hematology7% of their works
  3. 3Immunology5% of their works
  4. 4Pulmonary and Respiratory Medicine5% of their works
  5. 5Epidemiology4% of their works
  6. 6General Health Professions4% of their works

Research topics

Which keywords describe Mary A. Cifaldi's research?

The keywords of their largest research topics: Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis, Hemophagocytic Lymphohistiocytosis, Juvenile Idiopathic Arthritis, Community-Acquired Pneumonia and Medication Adherence.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Inflammation271 topic
  2. Rheumatoid Arthritis271 topic
  3. Ankylosing Spondylitis171 topic
  4. Spondyloarthritis171 topic
  5. Hemophagocytic Lymphohistiocytosis71 topic
  6. Juvenile Idiopathic Arthritis71 topic
  7. Community-Acquired Pneumonia51 topic
  8. Medication Adherence51 topic
  9. Pneumococcal Conjugate Vaccine51 topic
  10. Treatment Adherence51 topic
  11. Biosimilars41 topic
  12. Chronic Cough41 topic
  13. Cough Reflex Sensitivity41 topic
  14. Immunogenicity41 topic
  15. IL-1721 topic
  16. TH17 Cells21 topic

Where does Mary A. Cifaldi work?

Mary A. Cifaldi's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Mary A. Cifaldi have?

OpenAlex counts 38 works and 1,610 citations for Mary A. Cifaldi, an h-index of 22, ranking #1,133,370 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mary A. Cifaldi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.